More affordable versions of Hep C medicine are available from India

What is Generic Hep C Medicine

Generic Hepatitis C medicines are created to be exact copies of existing approved brand-name Hepatitis C medicines such as Harvoni or Epclusa. These Hep C meds are the same in dose rates, chemical composition, safety, strength, side effects, quality, and cure rates as the brand versions, but are much cheaper.

Generally a generic Hepatitis C medicine refers to a version of a medication used to treat Hepatitis C that is produced and marketed by a company other than the original manufacturer. For example Epclusa is manufactured by Gilead Sciences in the USA but by Hetero Pharmaceuticals in India. Accord to definitions by the USA’s FDA, generic medicines are essentially equivalent to the brand-name version in terms of active ingredients, dosage form, strength, route of administration, safety, efficacy, and intended use.

The FDA’s exact of a generic drug definition is:

“A generic drug is a medication created to be the same as an already marketed brand-name drug in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use. These similarities help to demonstrate bioequivalence, which means that a generic medicine works in the same way and provides the same clinical benefit as the brand-name medicine. In other words, you can take a generic medicine as an equal substitute for its brand-name counterpart.”

In the case of Hepatitis C, there are several direct-acting antiviral (DAA) medications that have been developed to effectively treat the infection. These medications target the Hepatitis C virus directly, suppressing its replication and allowing the immune system to clear the virus from the body.

Some commonly used generic DAA medications for Hepatitis C include:

1. Sofosbuvir + Ledipasvir (Harvoni)
2. Sofosbuvir + Daclatasvir (Sovaldi)
3. Sofosbuvir +Velpatasvir (Epclusa)

Availability and specific brand names of generic medications can vary by country. These n0n-brand versions of Hepatitis C medicines have played a crucial role in increasing access to treatment and reducing the overall cost of therapy, making them more affordable for patients.

There are two types of non-brand Hep C medicines. Firstly there are the licensed  Hep C meds. These are made under direct license from the owners of the brand medication. The companies that manufacture the licensed  Hep C meds have been given all the information on manufacturing these medicines from the brand owners in exchange for a royalty payment on all medication sold.

Part of the licensing agreement also requires that the maker of these Hep C meds meets certain quality assurance standards.

This means that licensed non-brand Hep C medication is identical to brand versions except in the colour of the pill and the price.

Licensed non-branded Hep C medicines are only made in India and the USA. Gilead Sciences granted licenses to manufacture Epclusa, Harvoni and Sovaldi to Indian pharmaceutical companies.

Unlicensed Hep C Medicines

Because the patents for Hepatitis C medicine are not recognized in all countries there are unlicensed versions of various Hepatitis C medicines.

Manufacturers of unlicensed Hep C medicines do not have access to the technical information that licensed manufacturers do, so they must figure things out themselves and often produce products that are not as effective as the brand versions.

Many unlicensed  medicines are made in countries with poor regulation of the pharmaceutical industry and quality is not assured. It is unwise to purchase or consume unlicensed  Hep C medicine.

What Hep C Medicines are available as cheaper “non-brand” versions?

Currently, there is no generic version of Mavyret however Mavyret is slightly inferior to the Sofosbuvir based Hep C treatments such as Epclusa and Harvoni.

For example, the combination of Sofosbuvir + Daclatasvir, which like Mavyret  is a pan-genotype Hep C treatment but Sofosbuvir + Daclatasvir has many advantages over Mavyret being easier to absorb and with less side effects. This is because Sofosbuvir + Daclatasvir is water-soluble, which means that it is more easily absorbed into the body than Mavyret.

Lastly, Sof + Dac is much cheaper than Mavyret

Off-brand versions of Epclusa are made in India and are about 2% more effective than Mavyret across all genotypes of Hepatitis C.

Here is a link to independent research comparing Mavyret with Sofosbuvir based Hep C treatments.

Trials show that Sovaldi + Daklinza (Sofosbuvir + Daclatasvir) is more effective than Mavyret

Policies Related to  Hepatitis C medicine Purchased Online from Greg Jefferys Hep C Buyers Club

Delivery Policy

Delivery of your  Hep C Treatment is generally by Express Airmail, which can be tracked online. A tracking number is supplied once the order has been shipped. So your Hepatitis C medicine is safe from dispatch to delivery at your home.

Delivery can take between 10 and 14 days depending on your location.

Refund Policy

A full refund, less shipping costs, is available for goods returned within 28 days unopened and in good condition.

Location

Affordable Medical Access International is a registered Australian company and all transactions occur in Australia

For more information click here to EMAIL ME

Privacy and Data Protection

Your Data and Personal details will not be shared with any person or other entity and will be deleted 12 months after the transaction is completed

Remember that when you buy your Hep C medication through Greg Jefferys’ Buyers’ Club:

Delivery is 100% Guaranteed

Your medication is 100% insured against any loss or damage.

Your medication is made under license from GILEAD SCIENCES in FDA and WHO approved facilities.

There is a 100% Money Back Guarantee if you are not cured Hepatitis C.

(Guarantee is provided if you take the recommended treatment for your Hepatitis C based on accepted international standards)